Zbinden G
Institute of Toxicology, Swiss Federal Institute of Technology, Schwerzenbach.
Trends Pharmacol Sci. 1990 Mar;11(3):104-7. doi: 10.1016/0165-6147(90)90194-d.
Despite recent changes in legislation in several countries and general reduction in the use of animals in biomedical research, the impatience of antivivisectionists to see reductions in animal experimentation shows no signs of abating. Gerhard Zbinden analyses the reasons for this continuing dissatisfaction, arguing that real progress has been made in biomedical research, but that the complexities of developing internationally recognized regulations constitute a barrier to rapid change in product safety testing methods.
尽管最近几个国家的立法有所变化，并且生物医学研究中动物的使用总体上有所减少，但反活体解剖者急于看到动物实验减少的急切心情丝毫没有减弱的迹象。格哈德·齐宾登分析了这种持续不满的原因，认为生物医学研究已经取得了实际进展，但制定国际认可的法规的复杂性构成了产品安全测试方法快速变革的障碍。
